Was Lloyd M. Yates’s Marsh & McLennan (MRSH) share sale under a Rule 10b5-1 plan?

The transaction was not reported as being under a Rule 10b5-1 trading plan. The Rule 10b5-1 affirmation box was not checked, indicating the sale was not designated as executed pursuant to a pre-arranged trading plan.

Marsh & McLennan director sells 12000 shares

Marsh & McLennan Companies director Lloyd M. Yates sold 12000 shares of Common Stock on July 23, 2026 at $175.6500 per share in an open-market or private transaction.

Filing Impact

(Neutral)

Filing Sentiment

(Negative)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

Marsh & McLennan Companies director Lloyd M. Yates sold 12000 shares of Common Stock on July 23, 2026 at $175.6500 per share in an open-market or private transaction. After this sale, he directly owned 12000.7500 shares, and the trade was not made under a Rule 10b5-1 plan.

Insider Trade Summary

Net Seller: 12,000 shares

Net Sell 1 txn

Insider Yates Lloyd M

Role Director

Sold 12,000 shs ($2.11M)

Type	Security	Shares	Price	Value
Sale	Common Stock	12,000	$175.65	$2.11M

Holdings After Transaction: Common Stock — 12,000.75 shares (Direct)

Key Figures

Shares sold: 12000 shares Sale price per share: $175.6500 per share Shares owned after sale: 12000.7500 shares +1 more

4 metrics

Shares sold 12000 shares Common Stock sold by director Lloyd M. Yates on 2026-07-23

Sale price per share $175.6500 per share Per-share price for the Common Stock sale on 2026-07-23

Shares owned after sale 12000.7500 shares Direct Marsh & McLennan Common Stock holdings after the reported transaction

Net shares sold 12000 shares Net sell shares reported in the transaction summary

Key Terms

Common Stock, open market, private transaction

3 terms

Common Stock financial

"Security title for the reported transaction is "Common Stock"."

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

open market financial

"Transaction code description notes a sale in "open market"."

An open market is a system where buying and selling of goods, services, or financial assets happen freely without restrictions or special controls. For investors, it means they can trade assets easily and quickly, which helps determine fair prices based on supply and demand. This environment encourages transparency and competition, making it easier to buy or sell with confidence.

private transaction financial

"Code description allows for a sale in a "private transaction"."

A private transaction is the sale or transfer of securities, assets, or ownership stakes carried out directly between a small number of parties rather than on a public exchange. For investors it matters because these deals are less visible and often less liquid than public trades, so pricing can be harder to verify, the investment can be harder to sell quickly, and buyers or sellers may gain strategic advantages not available in open markets — like negotiated terms similar to a private garage sale versus a crowded marketplace.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Marsh & McLennan (MRSH) report for Lloyd M. Yates?

Marsh & McLennan reported that director Lloyd M. Yates sold 12000 shares of Common Stock. The sale occurred on July 23, 2026 and was coded as a sale in an open-market or private transaction, reflecting a net disposition of shares.

How many Marsh & McLennan (MRSH) shares did Lloyd M. Yates sell and at what price?

Lloyd M. Yates sold 12000 Marsh & McLennan Common Stock shares at $175.6500 per share. The transaction was recorded as a non-derivative sale on July 23, 2026, with the price reported on a per-share basis.

What is Lloyd M. Yates’s remaining Marsh & McLennan (MRSH) ownership after this sale?

After the reported sale, Lloyd M. Yates directly owned 12000.7500 Marsh & McLennan shares. This figure reflects his direct Common Stock holdings immediately following the July 23, 2026 open-market or private transaction.

What type of security did Lloyd M. Yates trade in this Marsh & McLennan (MRSH) filing?

The transaction involved Marsh & McLennan Common Stock as a non-derivative security. The Form 4 entry specifies “Common Stock” as the security title, with all reported shares sold directly rather than through derivative instruments.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Accepted by SEC EDGAR 07/24/2026 - 04:05 PM EDT

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Yates Lloyd M

(Last)

(First)

(Middle)

C/O MARSH & MCLENNAN COMPANIES, INC.

1166 AVENUE OF THE AMERICAS

(Street)

NEW YORK

10036

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
MARSH & MCLENNAN COMPANIES, INC. [ MRSH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
07/23/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	07/23/2026		S		12,000	D	$175.65	12,000.75	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

	/s/ Tessa Patti, Attorney-in-fact	07/24/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR